JACQUELYN ADDINGTON: Open Payments
NPI 1053845966 · WARRENSBURG, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,030 in 80 payments from 24 companies in 2025. Trend: 2023 $2,632 · 2024 $2,523 · 2025 $3,030
Food & beverage: $2,972Education: $57
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $1,107 |
| GlaxoSmithKline, LLC. | 7 | $374 |
| GENZYME CORPORATION | 14 | $364 |
| Regeneron Healthcare Solutions, Inc. | 10 | $272 |
| Averitas Pharma Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $117 |
| Lundbeck LLC | 1 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $82 |
| UCB, Inc. | 3 | $81 |
| SANOFI-AVENTIS U.S. LLC | 1 | $57 |
Products named: DUPIXENT, FASENRA, NUCALA, BREZTRI, AIRSUPRA, QUTENZA, REXULTI, Bimzelx.
Industry payments across MO — which companies pay providers there.
